Full-Time

Director – Head

Clinical Scientist, Oncology

Confirmed live in the last 24 hours

Eikon Therapeutics

Eikon Therapeutics

201-500 employees

Biotech startup developing innovative medicines

AI & Machine Learning
Biotechnology

Compensation Overview

$200k - $218.5kAnnually

+ Bonus + Equity Compensation

Senior, Expert

New York, NY, USA + 1 more

More locations: Hayward, CA, USA

Requires onsite presence in California, New York, or New Jersey for a minimum of 3 days a week.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Google Cloud Platform
Requirements
  • Post Graduate Degree with 10+ years or a Bachelor's degree with 12+ years
  • Solid knowledge of clinical research regulatory requirements (e.g., GCP and ICH)
  • Ability to manage multiple competing priorities with good planning, time management and prioritization skills
  • Strong analytical skills with the ability to interpret clinical trial data and synthesize conclusions
  • Proficient scientific expertise to propose, design, and execute clinical research and development studies, and authors documents related to clinical trials, such as medical monitoring plan, SAPs, informed consent and clinical components of the Clinical Study Reports
  • Adept ability to interact with key stakeholders across Clinical Research & Development functional areas
  • Role requires proactive approach, strategic thinking and leadership in driving toward clinical study goals
  • Adept ability to Influence opinions and decisions of internal and external customers, across clinical development functional areas (e.g., Pharmacovigilance, Clinical Data Management, Clinical Research, Clinical Operations)
  • Expert problem solving, prioritization, conflict resolution and critical thinking skills
  • Strong communication, technical writing, and presentation skills experience
  • Significant experience within oncology therapeutic area.
Responsibilities
  • Responsible for leading the Clinical Scientist functional area, and specific aspects of clinical/scientific execution of clinical protocol(s). This may include:
  • Serving as the lead clinical scientist on the clinical trial team
  • Leading medical monitoring team in review and interpretation of clinical data/medical protocol deviations in collaboration with Clinical Research and Pharmacovigilance, to effectively implement program development strategy
  • Collaborating cross-functionally in the development of Protocol and related study materials (e.g., ICF documents / amendments); partnering with Clinical Operations on study deliverables
  • Ensure CRF design supports data collection in alignment with the Protocol in collaboration with Clinical Data Management/Programming
  • Collaborating cross-functionally to monitor clinical data to ensure quality, completeness, and integrity of trial conduct
  • Providing tactical/scientific mentorship to other clinical scientists
  • Responsible for assisting with the generation, analysis, and presentation of clinical data, including manuscripts, abstracts, and oral presentations (including authoring documents and slide preparation as appropriate)
  • Prepare, coordinate, and participate in internal/external committee meetings (i.e., SMC, DMC)
  • Apply proficient analytical knowledge and skills to understand how program objectives and design impact data analysis; identifies risks and designs mitigation strategies
  • Promotes consistent first line medical/clinical data review techniques and conventions across studies/programs.

Eikon Therapeutics develops new medicines in the pharmaceutical industry by studying biological systems to identify drug targets. They utilize a proprietary single-molecule tracking platform to visualize protein movements in living cells, combined with artificial intelligence and automation for precise molecular interaction analysis. Their diverse team integrates various scientific and engineering disciplines to create therapies aimed at improving the lives of patients with serious diseases. Eikon stands out from competitors by focusing on the dynamic aspects of biology rather than static chemical processes.

Company Stage

Series C

Total Funding

$750.8M

Headquarters

Hayward, California

Founded

2019

Growth & Insights
Headcount

6 month growth

7%

1 year growth

14%

2 year growth

62%
Simplify Jobs

Simplify's Take

What believers are saying

  • Eikon's recent acquisition of global rights to clinical-stage assets and a robust drug development pipeline positions it for significant growth and market impact.
  • The company's strategic partnerships, such as with Impact Therapeutics for PARP1 selective inhibitors, enhance its capabilities in developing targeted cancer therapies.
  • Eikon's expansion into a new 36,284-square-foot office space in Jersey City reflects its growth and commitment to scaling operations.

What critics are saying

  • The highly competitive biotech and pharmaceutical sectors require continuous innovation to maintain a competitive edge.
  • The integration of newly acquired assets and technologies may pose challenges in terms of operational alignment and resource allocation.

What makes Eikon Therapeutics unique

  • Eikon Therapeutics leverages proprietary single-molecule tracking (SMT) technology to visualize protein motion in living cells, setting it apart from competitors who rely on static snapshots of chemical processes.
  • The integration of advanced automation and artificial intelligence allows Eikon to inventory molecular interactions with unprecedented scale and precision.
  • Eikon's diverse team of scientists, engineers, and clinicians enables a multidisciplinary approach to drug development, enhancing innovation and problem-solving capabilities.

Help us improve and share your feedback! Did you find this helpful?